These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 7595530

  • 1. D4 receptors and schizophrenia.
    Strange PG, Vile JM.
    J Neurochem; 1995 Nov; 65(5):2381-3. PubMed ID: 7595530
    [No Abstract] [Full Text] [Related]

  • 2. Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride.
    Seeman P, Van Tol HH.
    J Neurochem; 1995 Mar; 64(3):1413-5. PubMed ID: 7861175
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
    Sumiyoshi T, Stockmeier CA, Overholser JC, Thompson PA, Meltzer HY.
    Brain Res; 1995 May 29; 681(1-2):109-16. PubMed ID: 7552267
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P, Guan HC, Van Tol HH.
    Nature; 1993 Sep 30; 365(6445):441-5. PubMed ID: 8413587
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Seeman P.
    Neuropsychopharmacology; 1992 Aug 30; 7(1):55-7; discussion 73-5. PubMed ID: 1388022
    [No Abstract] [Full Text] [Related]

  • 8. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
    Tang SW, Helmeste DM, Fang H, Li M, Vu R, Bunney W, Potkin S, Jones EG.
    Brain Res; 1997 Aug 08; 765(1):7-12. PubMed ID: 9310388
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Seeman P, Guan HC, Van Tol HH, Niznik HB.
    Synapse; 1993 Aug 08; 14(4):247-53. PubMed ID: 8248849
    [Abstract] [Full Text] [Related]

  • 11. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Wong DF.
    Neuropsychopharmacology; 1992 Aug 08; 7(1):69-72; discussion 73-5. PubMed ID: 1388023
    [No Abstract] [Full Text] [Related]

  • 12. Autoradiographic localization of the putative D4 dopamine receptor in rat brain.
    Defagot MC, Antonelli MC.
    Neurochem Res; 1997 Apr 08; 22(4):401-7. PubMed ID: 9130250
    [Abstract] [Full Text] [Related]

  • 13. Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.
    Seeman P, Niznik HB, Guan HC.
    Arch Gen Psychiatry; 1990 Dec 08; 47(12):1170-2. PubMed ID: 2244801
    [No Abstract] [Full Text] [Related]

  • 14. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
    Lahti RA, Evans DL, Stratman NC, Figur LM.
    Eur J Pharmacol; 1993 Jun 04; 236(3):483-6. PubMed ID: 8102973
    [Abstract] [Full Text] [Related]

  • 15. The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia.
    Marzella PL, Hill C, Keks N, Singh B, Copolov D.
    Biol Psychiatry; 1997 Oct 15; 42(8):648-54. PubMed ID: 9325557
    [Abstract] [Full Text] [Related]

  • 16. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ, Thurkauf A, Xu J, Yevich E, McInerney S, Shaw K, Tallman JF, Gallagher DW.
    J Pharmacol Exp Ther; 1997 Aug 15; 282(2):1020-7. PubMed ID: 9262371
    [Abstract] [Full Text] [Related]

  • 17. D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects.
    Lahti RA, Roberts RC, Conley RR, Cochrane EV, Mutin A, Tamminga CA.
    Neuroreport; 1996 Aug 12; 7(12):1945-8. PubMed ID: 8905699
    [Abstract] [Full Text] [Related]

  • 18. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N, Farde L, Halldin C, Swahn CG.
    Synapse; 1997 Apr 12; 25(4):321-5. PubMed ID: 9097390
    [Abstract] [Full Text] [Related]

  • 19. Brain sigma receptors labelled by [3H]nemonapride.
    Helmeste D, Tang SW, Fang H, Li M.
    Eur J Pharmacol; 1996 Apr 22; 301(1-3):R1-3. PubMed ID: 8773467
    [Abstract] [Full Text] [Related]

  • 20. [3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects.
    Dean B, Pavey G, Opeskin K.
    Neuropharmacology; 1997 Jun 22; 36(6):779-86. PubMed ID: 9225305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.